Oxycodone
Eija Kalso, Eija Kalso
Abstract
Oxycodone has been in clinical use since 1917. Parenteral oxycodone was used mainly for the treatment of acute postoperative pain whereas combinations, for example, oxycodone and acetaminophen, were used for moderate pain. Since the introduction of controlled-release oxycodone, it has been used to manage cancer-related pain and chronic non-cancer-related pain problems. Controlled studies have been performed in postoperative pain, cancer pain, osteoarthritis-related pain, and neuropathic pain due to postherpetic neuralgia and diabetic neuropathy. The pharmacodynamic effects of oxycodone are typical of a mu-opioid agonist. Oxycodone closely resembles morphine but it has some distinct differences, particularly in its pharmacokinetic profile. Being an old drug, the basic pharmacology of oxycodone has been a neglected field of research.
Source: PubMed
Kommende kliniske forsøg
-
NCT07826949Ikke rekrutterer endnuGliom | Neoplasma i hjernen | Tilbagevendende højgradige gliomer
-
NCT07826962Ikke rekrutterer endnu
-
NCT07826975Ikke rekrutterer endnu
-
NCT07826988Ikke rekrutterer endnuSeglcellesygdom | Vaso-okklusiv krise
-
NCT07827001RekrutteringHjernekræft | CNS kræft | Kræft i nervesystemet | Metastatisk Hjernekræft
-
NCT07827027Ikke rekrutterer endnu
-
NCT07827040RekrutteringVoksne | Digital Assistance med lavt syn | Synshandicap
-
NCT07827053Ikke rekrutterer endnuPancreas Ductal Adenocarcinom (PDAC)
-
NCT07827066Ikke rekrutterer endnuRygestop | AI-agent | Early-Stage Cancer
-
NCT07827131Ikke rekrutterer endnu